Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the only US FDA-approved medication for the treatment of gastroparesis. However, the FDA ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review.

Vanda Pharmaceuticals (VNDA) issued a letter to FDA Commissioner highlighting what the company considers a faulty gastroparesis NDA review.

With nutritional, pharmaceutical, and surgical options available for obesity, clinicians are being called upon to make ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review. As ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

After Vanda Pharmaceuticals’ phase 3 miss and FDA rejection for its stomach disorder candidate, CEO Mihael Polymeropoulos, ...

Paralytic drugs, or neuromuscular blocking agents (NMBAs), are powerful muscle relaxants used to prevent muscle movement during surgical procedures. They're also used during critical care, such as ...

There are many different types of vinegar on the market. Some of them are used for cooking, and others have other ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

According to the latest study from BCC Research, the demand for Conventional and Alternative Pain Treatment Markets is expected to grow from $96.2 billion in 2024 to $144.2 billion by the end of 2029, ...

Vanda Pharmaceuticals (NASDAQ:VNDA) has sent a letter to FDA Commissioner Robert Califf asserting that the review of the New ...